You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLARAVIS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Claravis, and when can generic versions of Claravis launch?

Claravis is a drug marketed by Teva Pharms Usa and is included in two NDAs.

The generic ingredient in CLARAVIS is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Claravis

A generic version of CLARAVIS was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLARAVIS?
  • What are the global sales for CLARAVIS?
  • What is Average Wholesale Price for CLARAVIS?
Drug patent expirations by year for CLARAVIS
Drug Prices for CLARAVIS

See drug prices for CLARAVIS

Drug Sales Revenue Trends for CLARAVIS

See drug sales revenues for CLARAVIS

Recent Clinical Trials for CLARAVIS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Oncology GroupPhase 2
Children's Oncology GroupN/A
National Cancer Institute (NCI)N/A

See all CLARAVIS clinical trials

Pharmacology for CLARAVIS
Drug ClassRetinoid

US Patents and Regulatory Information for CLARAVIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa CLARAVIS isotretinoin CAPSULE;ORAL 076356-001 Apr 11, 2003 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa CLARAVIS isotretinoin CAPSULE;ORAL 076135-001 Apr 11, 2003 AB1 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa CLARAVIS isotretinoin CAPSULE;ORAL 076135-002 Apr 11, 2003 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa CLARAVIS isotretinoin CAPSULE;ORAL 076135-003 May 11, 2006 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.